Experimental Study on the Compatibility of PD Flexible UHF Antenna Sensor Substrate with SF6/N2

The use of flexible, built-in, ultra-high-frequency (UHF) antenna sensors is an effective method to solve the weak high-frequency electromagnetic wave signal sensing of partial discharge (PD) inside gas-insulated switchgears (GISs), and the compatibility of flexible UHF antenna sensor substrate materials and SF6/N2 mixtures is the key to the realization of a flexible UHF antenna sensor inside a GIS. Based on this, this paper builds an experimental platform for the compatibility of a 30% SF6/70% N2 gas mixture and a PD flexible UHF antenna sensor substrate and conducts compatibility experiments between the 30% SF6/70% N2 gas mixture and PD flexible UHF antenna sensor substrate under different temperatures in combination with the actual operating temperature range of the GIS. In this article, a Fourier transform infrared spectrometer, scanning electron microscope and X-ray photoelectron spectrometer were used to test and analyze the gas composition, the surface morphology and the elemental change in the PD flexible UHF antenna sensor substrate, respectively. PET material will be slightly oxidized under the environment of a 30% SF6/70% N2 gas mixture at 110 °C, PI material will generate metal fluoride under the environment of a 30% SF6/70% N2 gas mixture and only PDMS material will remain stable under the environment of a 30% SF6/70% N2 gas mixture; therefore, it is appropriate to use PDMS substrate in the development of flexible UHF antenna sensors

A characterized ethanol extract of Rosa rugosa inhibits hepatic stellate cell activation through elevating Hint1 and subsequent upregulation of Smad7

Our study aimed to explore effects of a characterized ethanol extract of Rosa rugosa (ERS) on hepatic stellate cells (HSCs) activation and mouse liver fibrosis and their molecular mechanisms. ERS suppressed TGF-β1-induced activation of LX-2 HSCs. Moreover, ERS boosted Smad7 and inhibited TGF-β1-induced phosphorylation of Smad2/3. Knockdown of Smad7 eliminated protective effects of ERS. Furthermore, ERS elevated Hint1 whose expression was positively related with that of Smad7. Knockdown of Hint1 abolished ERS-mediated upregulation of Smad7 and subsequent suppression of LX-2 HSC activation. Suppressive effects of ERS on Smad2/3 signaling were also eliminated. In primary mouse HSCs, ERS potentiated Hint1/Smad7 axis and suppressed their spontaneous activation. Finally, it was unveiled that gavage of ERS dramatically mitigated mouse liver fibrosis provoked by CCl4. Our findings collectively indicated that ERS inhibits HSC activation and alleviates liver fibrosis. Mechanically, ERS elevates expression of Hint1 which suppresses TGF-β1 pathway via upregulating Smad7 in HSCs

Whole-transcriptome splicing profiling of E7.5 mouse primary germ layers reveals frequent alternative promoter usage during mouse early embryogenesis

Alternative splicing (AS) and alternative promoter (AP) usage expand the repertories of mammalian transcriptome profiles and thus diversify gene functions. However, our knowledge about the extent and functions of AS and AP usage in mouse early embryogenesis remains elusive. Here, by performing whole-transcriptome splicing profiling with high-throughput next generation sequencing, we report that AS extensively occurs in embryonic day (E) 7.5 mouse primary germ layers, and may be involved in multiple developmental processes. In addition, numerous RNA splicing factors are differentially expressed and alternatively spliced across the three germ layers, implying the potential importance of AS machinery in shaping early embryogenesis. Notably, AP usage is remarkably frequent at this stage, accounting for more than one quarter (430/1,648) of the total significantly different AS events. Genes generating the 430 AP events participate in numerous biological processes, and include important regulators essential for mouse early embryogenesis, suggesting that AP usage is widely used and might be relevant to mouse germ layer specification. Our data underline the potential significance of AP usage in mouse gastrulation, providing a rich data source and opening another dimension for understanding the regulatory mechanisms of mammalian early development

The R2R3-MYB transcription factor GhMYB1a regulates flavonol and anthocyanin accumulation in Gerbera hybrida

Anthocyanins and flavonols have vital roles in flower coloration, plant development, and defense. Because anthocyanins and flavonols share the same subcellular localization and common biosynthetic substrates, these pathways may compete for substrates. However, the mechanism regulating this potential competition remains unclear. Here, we identified GhMYB1a, an R2R3-MYB transcription factor involved in the regulation of anthocyanin and flavonol accumulation in gerbera (Gerberahybrida). GhMYB1a shares high sequence similarity with that of other characterized regulators of flavonol biosynthesis. In addition, GhMYB1a is also phylogenetically grouped with these proteins. The overexpression of GhMYB1a in gerbera and tobacco (Nicotianatabacum) resulted in decreased anthocyanin accumulation and increased accumulation of flavonols by upregulating the structural genes involved in flavonol biosynthesis. We further found that GhMYB1a functions as a homodimer instead of interacting with basic helix-loop-helix cofactors. These results suggest that GhMYB1a is involved in regulating the anthocyanin and flavonol metabolic pathways through precise regulation of gene expression. The functional characterization of GhMYB1a provides insight into the biosynthesis and regulation of flavonols and anthocyanins

Discovery of (2E)-3-{2-Butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile

A series of 3-(1,2-disubstituted-1H-benzimidazol-5-yl)-N-hydroxyacrylamides (1) were designed and synthesized as HDAC inhibitors. Extensive SARs have been established for in vitro potency (HDAC I enzyme and COLO 205 cellular IC(50)), liver microsomal stability (t(1/2)), cytochrome P450 inhibitory (3A4 IC(50)), and clogP, among others. These parameters were fine-tuned by carefully adjusting the substituents at positions 1 and 2 of the benzimidazole ring. After comprehensive in vitro and in vivo profiling of the selected compounds, SB939 (3) was identified as a preclinical development candidate. 3 is a potent pan-HDAC inhibitor with excellent druglike properties, is highly efficacious in in vivo tumor models (HCT-116, PC-3, A2780, MV4-11, Ramos), and has high and dos-proportional oral exposures and very good ADME, safety, and pharmaceutical properties. When orally dosed to tumor-bearing mice, 3 is enriched in tumor tissue which may contribute to its potent antitumor activity and prolonged duration of action. 3 is currently being tested in phase I and phase II clinical trials